These, however, must be preceded by mutations in genes such DNMT3A, NPM1, FLT3, or RAS, which are essential to initiating leukemogenesis, all together contributing to disordered cellular proliferation and upregulation of anti-apoptotic genes, commonly found in AML patients [71]. Here, DNMT3A is linked to acute myeloid leukemia.